Clinical Trials Logo

Hospital Readmission clinical trials

View clinical trials related to Hospital Readmission.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04422041 Completed - Newborn Clinical Trials

Comparison of Early Versus Very Early Postnatal Discharge on Hospital Readmissions in Newborns

Start date: July 1, 2016
Phase: N/A
Study type: Interventional

This study compared hospital readmission and complications between very early discharge and early discharge in healthy newborn patients.

NCT ID: NCT04306172 Completed - Clinical trials for Hospital Readmission

Validation of EPIC's Readmission Risk Model, the LACE+ Index and SQLape as Predictors of Unplanned Hospital Readmissions

Start date: March 10, 2020
Phase:
Study type: Observational

The primary objective of this study is to externally validate the EPIC's Readmission Risk model and to compare it with the LACE+ index and the SQLape Readmission model. As secondary objective, the EPIC's Readmission Risk model will be adjusted based on the validation sample, and finally, it´s performance will be compared with machine learning algorithms.

NCT ID: NCT03751319 Completed - Quality of Life Clinical Trials

Geriatric Assessment and Intervention for Older Patients With Frailty in the Emergency Department

GAOPS
Start date: December 11, 2018
Phase: N/A
Study type: Interventional

Comprehensive Geriatric Assessment (CGA) is an established approach for better detection of frailty-related problems and includes individualized treatment plan with multi-discipline supportive and treating measures for the older frailty patients. However, there is limited evidence of feasibility and efficacy of the CGA when provided in the emergency department setting. In the GAOPS-study the efficacy of the CGA in emergency department setting will be studied by randomized controlled study protocol. We aim to study if the CGA provided in the ED is feasible, safe and efficient method when added with standard emergency care for older frail patients.

NCT ID: NCT03594500 Completed - Hearing Loss Clinical Trials

Hearing Impairment, Strategies, and Outcomes in Emergency Departments

Hear-VA
Start date: March 18, 2019
Phase: N/A
Study type: Interventional

Aim 1: Establish the feasibility of screening for hearing loss in the ED Aim 2: Determine the acceptability of the screening procedure (among the ED population) Aim 3: Derive a preliminary estimate of the effect size of primary outcomes Aim 4: Identify the evidence that decision makers in Veteran Affair Medical Centers, ED and Audiology Services need to commit to this approach

NCT ID: NCT03046771 Completed - Fall Clinical Trials

Transport PLUS Intervention

Start date: January 19, 2017
Phase: N/A
Study type: Interventional

Hypothesis: 'Transport PLUS,' a low cost, easily generalizable intervention performed by Emergency Medical Technicians while transporting a patient home from the hospital, can improve transitions of care and improve patient safety following hospitalization as measured by decreased rates of falls and reduced rates of return to the hospital.

NCT ID: NCT02763202 Completed - Clinical trials for Hospital Readmission

Aiming to Improve Readmissions Through InteGrated Hospital Transitions

AIRTIGHT
Start date: February 8, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to better enhance transitions of care for the highest risk, complex patients, Carolinas HealthCare System (CHS) has designed an Integrated Practice Unit, called Transition Services (CHS-TS).CHS-TS aims to improve patient outcomes through innovative approaches that leverage analytics and technology, while bridging care coordination and communication gaps. During their hospitalization, CHS-TS patients enter into a transition pathway that includes the following key services: integrated access to medical, pharmacist, and specialty providers; access to CHS disease specific management programs; dedicated care management services delivered in home and at the clinic; lab and infusion services; palliative care consultations when appropriate; and paramedicine for 24 hour support. AIRTIGHT (Aiming to Improve Readmissions Through InteGrated Hospital Transitions) is a pragmatic, randomized quality improvement evaluation, which seeks to evaluate the effects of the role-out of CHS-TS services for patients at high risk for a 30-day readmission. AIRTIGHT will test the hypothesis that patients that receive care through CHS-TS will have a lower all cause, 30-day readmission rate than patients that receive usual care.

NCT ID: NCT01619098 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population

Start date: October 2011
Phase: N/A
Study type: Interventional

Hospital readmissions are common, costly, and potentially preventable. They are also potentially responsive to health system interventions. However, it is uncertain which components of care transition interventions are efficacious, for which populations, and at what cost. This randomized controlled study is part of a larger project that will evaluate a three-tiered quality improvement (QI) intervention intended to reduce hospital readmissions within 30 days post-discharge from an urban safety net hospital that serves a racially and linguistically diverse population (the randomized controlled study evaluates Tier 3). Few studies have evaluated care transition interventions to reduce readmissions among low-income, diverse patient populations, and the accumulated evidence on the effects of these multi-faceted interventions on readmission rates has been inconclusive. This project will take advantage of a unique sequence of three QI innovations to reduce hospital readmissions implemented beginning in 2007 in an integrated safety net health care system. The "discharge-transfer" tiers are as follows: 1) Tier 1 includes a comprehensive, individualized home care plan (HCP) reviewed by the medical service floor nurse with the patient prior to discharge; 2) Tier 2 adds the electronic transmission of the HCP to the patient's primary care medical home where, on the business day following discharge, a Registered Nurse makes an outreach telephone call to the discharged patient to confirm comprehension of the HCP and to address medical questions or needs; 3) Tier 3 further adds a community health worker, the Patient Navigator, to participate in bedside discussions to develop rapport and learn about patients' home situations, weekly outreach calls to assess patients' needs and to facilitate communication between the patient and the primary care team, and reminder calls to patients prior to all medical appointments to eliminate barriers to outpatient follow-up. The Aim of the study being registered is to evaluate the effects of an ongoing randomized natural experiment on readmissions, health care use, adherence to medication instructions, and preparedness for discharge. This natural experiment features random assignment to one of two QI interventions, Tier 2 or Tier 3, and exclusively targets patients at high risk for readmission, those with one or more of the following risk factors for readmission: discharge diagnosis of congestive heart failure or COPD; length of stay > 3 days; age > 60; or previous hospitalization within the past six months. The investigators hypothesize that the Patient Navigator intervention (Tier 3) compared to usual care (Tier 2) will increase the rates of 30-day post-discharge PCP visits; reduce 30-day hospital readmission rates; and reduce the total number of days in hospital in the 180 days following the index admission for high risk patients. The investigators further expect that the PN intervention will improve patient adherence to medication instructions in the HCP and reduce the probability of reported problems with post-discharge care.

NCT ID: NCT01578525 Completed - Elderly Clinical Trials

Medication Safety of Elderly Patients in Hospital and Ambulatory Setting

Start date: April 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether additional pharmaceutical care for elderly patients (home-cared patients, nursing-home residents) has a positive impact on drug-related readmissions.

NCT ID: NCT01440907 Completed - Clinical trials for Hospital Readmission

Study of the Impact of a Hospital Discharge Care Coordination Program in an Elderly Population

Start date: May 2011
Phase: N/A
Study type: Interventional

The purpose of this research study is to evaluate the effect of a health information exchange (HIE)-supported care coordination package on 30-day readmission rates in a frail elderly population.

NCT ID: NCT00550264 Completed - Clinical trials for Hospital Readmission

Study of Physician Awareness of and Communication About Patient Readmissions to the Hospital

Start date: February 2007
Phase: N/A
Study type: Interventional

Patients admitted to inpatient medicine services often require early hospital readmission, and often they are readmitted to different physician or team, potentially without the knowledge of the prior physician or team. Thus, physicians may lose the opportunity to share valuable information about readmitted patients, which may be detrimental to continuity of care and patient safety. The purpose of this study is to determine baseline awareness and communication rates among physicians regarding readmissions, and then measure the effect of automatic notification on these rates.